BIOE logo

Bio Essence OTCPK:BIOE Stock Report

Last Price

US$0.32

Market Cap

US$12.2m

7D

7.0%

1Y

n/a

Updated

22 Dec, 2024

Data

Company Financials

Bio Essence Corporation

OTCPK:BIOE Stock Report

Market Cap: US$12.2m

BIOE Stock Overview

Operates as an herbal health, diet, and nutrition company in the United States. More details

BIOE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bio Essence Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bio Essence
Historical stock prices
Current Share PriceUS$0.32
52 Week HighUS$10.81
52 Week LowUS$0.15
Beta14.16
1 Month Change23.46%
3 Month Change-51.36%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-35.80%

Recent News & Updates

Recent updates

Shareholder Returns

BIOEUS PharmaceuticalsUS Market
7D7.0%-1.5%-2.4%
1Yn/a7.9%23.4%

Return vs Industry: Insufficient data to determine how BIOE performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how BIOE performed against the US Market.

Price Volatility

Is BIOE's price volatile compared to industry and market?
BIOE volatility
BIOE Average Weekly Movement58.6%
Pharmaceuticals Industry Average Movement10.5%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: BIOE's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BIOE's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200012Yin Yanwww.bioessencecorp.com

Bio Essence Corporation operates as an herbal health, diet, and nutrition company in the United States. It targets and develops traditional Chinese medicines (TCM) in the form of single herbs, granules, capsules, pills, and tablets; offers special formulation, original equipment manufacturing, and private label services to practitioners and other companies; and manufactures and distributes health supplement products. The company sells its products through TCM practitioners, online websites, brick-and-mortar stores, and other channels.

Bio Essence Corporation Fundamentals Summary

How do Bio Essence's earnings and revenue compare to its market cap?
BIOE fundamental statistics
Market capUS$12.20m
Earnings (TTM)-US$1.72m
Revenue (TTM)US$312.62k

39.0x

P/S Ratio

-7.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOE income statement (TTM)
RevenueUS$312.62k
Cost of RevenueUS$54.92k
Gross ProfitUS$257.71k
Other ExpensesUS$1.98m
Earnings-US$1.72m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.045
Gross Margin82.43%
Net Profit Margin-549.64%
Debt/Equity Ratio-57.6%

How did BIOE perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:13
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bio Essence Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution